Prediction of Extubation Readiness in Extreme Preterm Infants by the Automated Analysis of CardioRespiratory Behavior
NCT ID: NCT01909947
Last Updated: 2019-04-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
266 participants
OBSERVATIONAL
2013-09-30
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Multicentre Mixed Methods Study to Explore Extubation Practices and Respiratory Outcomes in Extremely Preterm Neonates.
NCT06808997
Exercise Intervention to Rescue the Adverse Effect of Preterm Birth on Cardiovascular and Pulmonary Health.
NCT03504215
Prematurity-Related Ventilatory Control
NCT03464396
Non-invasive Support in Extremely Preterm Infants
NCT02723123
Pilot Study to Assess Safety and Feasibility of Resuscitation of Preterm Infants With Controlled Volume of Air/Oxygen
NCT00157989
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intubated extreme preterm infants
Infants with a birth weight ≤ 1250 grams and requiring endotracheal tube and mechanical ventilation
Cardiorespiratory signal acquisition
Cardiorespiratory signals will measure heart rate (using electrocardiography), chest and abdominal movements (using respiratory inductance plethysmography) and oxygen saturation (using pulse oximetry). Data will be acquired during 2 recording periods:
1. A 60-minute period while the infant receives any mode of conventional mechanical ventilation
2. A 5-minute period prior to extubation while the mode of ventilation is switched to endotracheal tube CPAP (Continuous Positive Airway Pressure), so that the respiratory pattern will be controlled by the infant
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiorespiratory signal acquisition
Cardiorespiratory signals will measure heart rate (using electrocardiography), chest and abdominal movements (using respiratory inductance plethysmography) and oxygen saturation (using pulse oximetry). Data will be acquired during 2 recording periods:
1. A 60-minute period while the infant receives any mode of conventional mechanical ventilation
2. A 5-minute period prior to extubation while the mode of ventilation is switched to endotracheal tube CPAP (Continuous Positive Airway Pressure), so that the respiratory pattern will be controlled by the infant
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Need for endotracheal tube mechanical ventilation
Exclusion Criteria
* Infants with congenital heart disease and cardiac arrhythmias
* Infants receiving vasopressor or sedative drugs at the time of extubation
* Infants extubated directly from high frequency ventilation
* Infants extubated to room air, oxyhood or low-flow nasal cannula
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Wayne State University
OTHER
Brown University
OTHER
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Guilherme Sant'Anna, MD
Associate Professor of Pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guilherme M Sant'Anna, MD
Role: STUDY_CHAIR
McGill University
Guilherme M Sant'Anna, MD
Role: PRINCIPAL_INVESTIGATOR
McGill University
Robert E Kearney, PhD
Role: PRINCIPAL_INVESTIGATOR
McGill University
Wissam Shalish, MD
Role: PRINCIPAL_INVESTIGATOR
McGill University
Karen A Brown, MD
Role: PRINCIPAL_INVESTIGATOR
McGill University
Doina Precup
Role: PRINCIPAL_INVESTIGATOR
McGill University
Sanjay Chawla, MD
Role: PRINCIPAL_INVESTIGATOR
Wayne State University
Martin Keszler, MD
Role: PRINCIPAL_INVESTIGATOR
Brown University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wayne State University
Detroit, Michigan, United States
Women and Infants Hospital of Rhode Island
Providence, Rhode Island, United States
Royal Victoria Hospital
Montreal, Quebec, Canada
Montreal Children's Hospital
Montreal, Quebec, Canada
Jewish General Hospital
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Alarcon-Martinez T, Latremouille S, Kovacs L, Kearney RE, Sant'Anna GM, Shalish W. Clinical usefulness of reintubation criteria in extremely preterm infants: a cohort study. Arch Dis Child Fetal Neonatal Ed. 2023 Nov;108(6):643-648. doi: 10.1136/archdischild-2022-325245. Epub 2023 May 16.
Shalish W, Kanbar LJ, Rao S, Robles-Rubio CA, Kovacs L, Chawla S, Keszler M, Precup D, Brown K, Kearney RE, Sant'Anna GM. Prediction of Extubation readiness in extremely preterm infants by the automated analysis of cardiorespiratory behavior: study protocol. BMC Pediatr. 2017 Jul 17;17(1):167. doi: 10.1186/s12887-017-0911-z.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
288299
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
12-387-PED
Identifier Type: OTHER
Identifier Source: secondary_id
APEX 01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.